文献速递糖尿病肥胖与代谢综合征

2型糖尿病合并严重精神疾病患者的心血管风险管理:一项队列研究

Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
PubMed 文献 · Diabetologia · 2024-02-26

该回顾性队列研究纳入苏格兰2004至2020年诊断的291,644例2型糖尿病成人,按严重精神疾病状态比较心血管风险管理。合并严重精神疾病者胆固醇达标率较低但差异并非全部有统计学意义,收缩压达标率反而更高,既往有心血管疾病者他汀处方几率更低。

要点

  • 合并严重精神疾病者胆固醇达标率较低,但差异并非所有疾病均达统计学显著。
  • 合并精神分裂症者收缩压达标几率更高(男性调整OR 1.72,女性OR 1.64)。
  • 既往有心血管疾病者合并严重精神疾病时他汀处方几率更低,1年后仍持续。

核心结论

  • 研究发现按严重精神疾病状态存在胆固醇达标和他汀处方的差异,这强化了针对心血管疾病二级预防他汀处方进行临床审查的重要性,尤其在严重精神疾病患者中。

研究设计与样本

  • 采用链接电子数据进行的回顾性队列研究,纳入苏格兰2004至2020年间诊断的2型糖尿病成人,从住院记录确定严重精神疾病史。
  • 共纳入291,644例2型糖尿病个体,其中1.0%有精神分裂症、0.5%有双相障碍、3.3%有重性抑郁。
  • 使用逻辑回归比较诊断后1年总胆固醇、收缩压和HbA1c目标水平达标情况,以及诊断时和1年后他汀处方获得情况,并校正社会人口学因素和临床病史。

主要发现

  • 合并严重精神疾病者更不可能达到胆固醇目标,尽管该差异并非所有疾病均达统计学显著。
  • 合并严重精神疾病者比无严重精神疾病者更可能达到收缩压目标,效应估计在精神分裂症中最大(男性:调整OR 1.72;95% CI 1.49, 1.98;女性:OR 1.64;95% CI 1.38, 1.96)。
  • HbA1c目标达标情况因严重精神疾病类别和性别而异。
  • 在无既往心血管疾病者中,合并严重精神疾病者在糖尿病诊断时和1年后他汀处方情况相似或更好。
  • 在既往有心血管疾病者中,严重精神疾病与糖尿病诊断时他汀处方几率更低相关(精神分裂症:OR 0.54;95% CI 0.43, 0.68;双相障碍:OR 0.75;95% CI 0.56, 1.01;重性抑郁:OR 0.92;95% CI 0.83, 1.01),该差异在1年后总体持续存在。

临床怎么用

  • 作者认为,研究结果强化了针对心血管疾病二级预防他汀处方进行临床审查的重要性,尤其在严重精神疾病患者中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to compare cardiovascular risk management among people with type 2 diabetes according to severe mental illness (SMI) status. METHODS: We used linked electronic data to perform a retrospective cohort study of adults diagnosed with type 2 diabetes in Scotland between 2004 and 2020, ascertaining their history of SMI from hospital admission records. We compared total cholesterol, systolic BP and HbA1c target level achievement 1 year after diabetes diagnosis, and receipt of a statin prescription at diagnosis and 1 year thereafter, by SMI status using logistic regression, adjusting for sociodemographic factors and clinical history. RESULTS: We included 291,644 individuals with type 2 diabetes, of whom 1.0% had schizophrenia, 0.5% had bipolar disorder and 3.3% had major depression. People with SMI were less likely to achieve cholesterol targets, although this difference did not reach statistical significance for all disorders. However, people with SMI were more likely to achieve systolic BP targets compared to those without SMI, with effect estimates being largest for schizophrenia (men: adjusted OR 1.72; 95% CI 1.49, 1.98; women: OR 1.64; 95% CI 1.38, 1.96). HbA1c target achievement differed by SMI disorder and sex. Among people without previous CVD, statin prescribing was similar or better in those with vs those without SMI at diabetes diagnosis and 1 year later. In people with prior CVD, SMI was associated with lower odds of statin prescribing at diabetes diagnosis (schizophrenia: OR 0.54; 95% CI 0.43, 0.68, bipolar disorder: OR 0.75; 95% CI 0.56, 1.01, major depression: OR 0.92; 95% CI 0.83, 1.01), with this difference generally persisting 1 year later. CONCLUSIONS/INTERPRETATION: We found disparities in cholesterol target achievement and statin prescribing by SMI status. This reinforces the importance of clinical review of statin prescribing for secondary prevention of CVD, particularly among people with SMI.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ter Braake JG, Fleetwood KJ, Vos RC, et al. Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study. Diabetologia. 2024. PMID: 38409440. doi:10.1007/s00125-024-06111-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。